Bio

Thomas Danielski is a partner in the firm’s securities and public companies group. Tom regularly represents publicly traded companies, underwriters and private equity funds and their portfolio companies in initial public offerings, follow-on and secondary public offerings, Rule 144A/Reg S financings and other strategic transactions. In addition, he advises clients on securities law compliance and general corporate matters. His clients have included Paratek Pharmaceuticals, Zai Lab, Beam Therapeutics, LianBio, Vapotherm, Verastem, Provention Bio, Alibaba, Goldman Sachs, J.P. Morgan, Morgan Stanley, Jefferies, Cowen, TPG Capital and Thomas H. Lee Partners. Prior to joining Ropes & Gray, Tom worked as a CPA at Ernst & Young where he primarily focused on public company financial statement audits and Sarbanes-Oxley compliance.